We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IHE market cap is 698.5M. The company's latest EPS is USD 11.1639 and P/E is 6.45.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.32M | 6.16M | 7.7M | 8.5M | 10.18M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -34.67M | 96.39M | 39.74M | -36.48M | 108.29M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 285.03M | 370.66M | 419.71M | 396.15M | 686.42M |
| Total Liabilities | 8.62M | 15.89M | 11.94M | 18.99M | 27.69M |
| Total Equity | 276.4M | 354.76M | 407.77M | 377.16M | 658.73M |
| Market Cap | 698.5M |
| Price to Earnings Ratio | 6.45 |
| Price to Sales Ratio | 68.63 |
| Price to Cash Ratio | 1.02k |
| Price to Book Ratio | 1.06 |
| Dividend Yield | - |
| Shares Outstanding | 9.7M |
| Average Volume (1 week) | 41.44k |
| Average Volume (1 Month) | 59.38k |
| 52 Week Change | 3.84% |
| 52 Week High | 72.94 |
| 52 Week Low | 62.675 |
| Spread (Intraday) | 2.92 (3.98%) |
| Company Name | iShares US Pharmaceuticals |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ishares.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
